EPCAM and lung adenocarcinoma: EPCAM promotes proliferation, metastasis, and invasion of tumor cells, but overexpressed EPCAM is associated with a better prognosis in patients with adenocarcinoma of the lung, breast and gall bladder cancer, and squamous cell carcinoma of the esophagus [62].